Treatment advances of macular edema caused by retinal vein occlusion

HAN Zhongshu; YU Jinqiang

doi:10.7619/jcmp.202016035

Journal of Clinical Medicine in Practice > 2020 > 24(16): 122-128. > DOI: 10.7619/jcmp.202016035

HAN Zhongshu, YU Jinqiang. Treatment advances of macular edema caused by retinal vein occlusion[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 122-128. DOI: 10.7619/jcmp.202016035

Citation:

HAN Zhongshu, YU Jinqiang. Treatment advances of macular edema caused by retinal vein occlusion[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 122-128. DOI: 10.7619/jcmp.202016035

Citation:

HAN Zhongshu, YU Jinqiang. Treatment advances of macular edema caused by retinal vein occlusion[J]. Journal of Clinical Medicine in Practice, 2020, 24(16): 122-128. DOI: 10.7619/jcmp.202016035

PDF (930 KB)

Treatment advances of macular edema caused by retinal vein occlusion

HAN Zhongshu,
YU Jinqiang^,

Training Base of Hubei University of Medicine of Jinzhou Medical University, Shiyan, Hubei, 442000

More Information

Received Date: May 10, 2020
Available Online: September 14, 2020

Graphical Abstract

Abstract

Abstract

Retinal vein occlusion(RVO)is the one of common retinal vascular diseases, monocular lesion frequently occurring in these patients, and their visual acuity often declines painlessly. The most common complication of RVO is macular edema(ME), which is the most common reason for RVO vision loss, so active treatment for ME is the key to increase the vision of RVO patients. The treatments for RVO, such as laser, drugs, and surgery, etc., have become hotpots in researches, but their clinical curative effect and safety are still unknown due to lack of large-scale prospective clinical trial data. This article reviewed the recent advances in the treatment of RVO so as to blaze new trails for better treatments.
- retinal vein obstruction,
- macular edema,
- retinal vascular disease,
- pathogenesis,
- vascular endothelial growth factor

FullText(HTML)

References (62)

References

王彬, 贾淑琴, 霍建新. 视网膜静脉阻塞的诊断与治疗研究进展[J]. 国际眼科杂志, 2014, 14(7): 1227-1230.

FENG X X, LI C, SHAO W W, et al. Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report[J]. Int J Ophthalmol, 2018, 11(3): 429-437.

OKAWADA H, SAITO Y, IWABUCHI S, et al. Relationship between vascular endothelial growth factor and macular edema in retinal vein branch obstruction[J]. Clin Ophthalmol, 2018, 12: 1379-1382.

NOMA H, YASUDA K, MINEZAKI T, et al. Changes of retinal flow volume after intravitreal injection of bevacizumab in branch retinal vein occlusion with macular edema: a case series[J]. BMC Ophthalmol, 2016, 16(1): 61.

TAGUCHI M, SAKURAI Y, KANDA T, et al. Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report[J]. Int Med Case Rep J, 2017, 10: 139-141.

PONTO K A, SCHARRER I, BINDER H, et al. Hypertension and multiple cardiovascular risk factors increase the risk for retinal vein occlusions: results from the Gutenberg Retinal Vein Occlusion Study[J]. J Hypertens, 2019, 37(7): 1372-1383.

BERTELMANN T, FRANK H U, FUCHS H A, et al. Branch retinal vein occlusion, macular ischemia, and intravitreal anti-VEGF therapy[J]. Case Rep Ophthalmol, 2017, 8(1): 271-278.

FUMA S, NISHINAKA A, INOUE Y, et al. A pharmacological approach in newly established retinal vein occlusion model[J]. Sci Rep, 2017, 7: 43509.

KOYLU M T, KUCUKEVCILIOGLU M, ERDURMAN F C, et al. Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: a case-control study[J]. Ophthalmic Genet, 2017, 38(4): 352-356.

WEGER M, STANGER O, DEUTSCHMANN H, et al. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion[J]. Ophthalmology, 2002, 109(6): 1105-1109.

CLAUDIO C, GIUSEPPE A, ELENA B, et al. Anti-VEGF Therapy for Retinal Vein Occlusions[J]. Current Drug Targets, 2016, 17(3): 328-326.

SHAN L, ZHENG M, ZHANG Y, et al. Correlation of vascular endothelial growth factor production with photochemical reaction-induced retinal edema[J]. Chin Med J, 2016, 129(24): 2944-2950.

THOMPSON J T. Cataract formation and other complications of intravitreal triamcinolone for macular edema[J]. Am J Ophthalmol, 2006, 141(4): 629-637.

KOROBELNIK J F, KODJIKIAN L, DELCOURT C, et al. Two-year, prospective, multicenter study of the use of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in the clinical setting in France[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(12): 2307-2318.

TANG L L, ZHAO H J, LU H W. Triamcinolone acetonide with laser photocoagulation for macular edema caused by retinal vein occlusion[J]. International Eye Science, 2016, 16(5): 975-977.

TULTSEVA S N, ASTAKHOV Y S, NOVIKOV S A, et al. Alternative ways to optimize treatment for retinal vein occlusion with peripheral capillary non-perfusion: a pilot study[J]. Arq Bras Oftalmol, 2017, 80(4): 224-228.

CAMPOCHIARO P A, HAFIZ G, MIR T A, et al. Scatter photocoagulation does not reduce macular edema or treatment burden in patients with retinal vein occlusion: the RELATE trial[J]. Ophthalmology, 2015, 122(7): 1426-1437.

KARTASASMITA A S, TAKARAI S, SWITANIA A, et al. Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion[J]. Clin Ophthalmol, 2016, 10: 2135-2140.

GAWECKI M, JASZCZUK-MACIEJEWSKA A, JURSKA-JASKO A, et al. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser[J]. Graefes Arch Clin Exp Ophthalmol, 2017, 255(12): 2299-2306.

INAGAKI K, OHKOSHI K, OHDE S, et al. Comparative efficacy of pure yellow(577-nm)and 810-nm subthreshold micropulse laser photocoagulation combined with yellow(561-577-nm)direct photocoagulation for diabetic macular edema[J]. Jpn J Ophthalmol, 2015, 59(1): 21-28.

马莹, 滕妍, 栗莉, 等. 微脉冲激光治疗仪在糖尿病视网膜病变治疗中的应用研究[J]. 中国医学装备, 2018, 15(11): 102-104.

喻晓兵. 微脉冲激光治疗黄斑水肿的临床观察[J]. 中国激光医学杂志, 2016, 25(5): 311-312.

PARODI M B, IACONO P, BANDELLO F. Subthreshold grid laser versus intravitreal bevacizumab as second-line therapy for macular edema in branch retinal vein occlusion recurring after conventional grid laser treatment[J]. Graefes Arch Clin Exp Ophthalmol, 2015, 253(10): 1647-1651.

陈立军, 王雨生, 马吉献, 等. 二步法激光诱导脉络膜视网膜静脉吻合术治疗兔视网膜中央静脉阻塞的疗效[J]. 国际眼科杂志, 2006, 6(1): 64-67.

苏晶, 刘新泉. 不同剂量曲安奈德玻璃体腔注射治疗视网膜静脉阻塞性黄斑水肿[J]. 国际眼科杂志, 2018, 18(8): 1397-1402.

林芳, 齐美华, 赵静. 曲安奈德与雷珠单抗玻璃体腔注射治疗视网膜静脉阻塞继发黄斑水肿的疗效观察[J]. 世界最新医学信息文摘, 2015, 15(78): 120-120.

沈兵. 曲安奈德联合雷珠单抗治疗视网膜静脉阻塞继发黄斑水肿的临床研究[J]. 黑龙江医药, 2018, 31(3): 541-543.

牛建军, 崔兰, 李顺利. 玻璃体内注射曲安奈德对视网膜静脉阻塞黄斑囊样水肿的疗效观察[J]. 世界最新医学信息文摘, 2018, 18(36): 23-24.

DEMIR M, OBA E, GUVEN D, et al. Results of intravitreal triamcinolone acetonide in patients with macular edema secondary to branch retinal vein occlusion[J]. Int J Clin Pharm, 2014, 36(2): 438-442.

赵宏锟, 吴敏, 李云琴. 地塞米松玻璃体植入剂应用进展[J]. 国际眼科杂志, 2019, 19(6): 960-963.

SCARAMUZZI M, QUERQUES G, SPINA C L, et al. Repeated intravitreal dexamethasone implant(ozurdex)for diabetic macular edema[J]. Retina, 2015, 35(6): 1216-1222.

BLANC J, DESCHASSE C, KODJIKIAN L, et al. Safety and long-term efficacy of repeated dexamethasone intravitreal implants for the treatment of cystoid macular edema secondary to retinal vein occlusion with or without a switch to anti-VEGF agents: a 3-year experience[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(8): 1441-1448.

谷潇雅, 戴虹, 喻晓兵. 地塞米松玻璃体腔植入剂治疗视网膜静脉阻塞继发黄斑水肿一年临床观察[J]. 中华眼底病杂志, 2018, 34(3): 221-227.

LI X X, WANG N L, LIANG X L, et al. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(1): 59-69.

MISHRA S K, GUPTA A, PATYAL S, et al. Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety[J]. Int J Retina Vitreous, 2018, 4: 13.

高婧, 刘迪丰, 蔡林. 雷珠单抗临床应用新进展概述[J]. 中国药师, 2015, 18(3): 479-482.

AVERY R L, CASTELLARIN A A, STEINLE N C, et al. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD[J]. Br J Ophthalmol, 2014, 98(12): 1636-1641.

吴李鑫, 张悦, 刘海芸. 玻璃体腔注射雷珠单抗联合激光治疗视网膜中央静脉阻塞继发黄斑水肿[J]. 中国实用眼科杂志, 2015(9): 1004-1007.

KORNHAUSER T, SCHWARTZ R, GOLDSTEIN M, et al. Bevacizumab treatment of macular edema in CRVO and BRVO: long-term follow-up.(BERVOLT study: Bevacizumab for RVO long-term follow-up)[J]. Graefes Arch Clin Exp Ophthalmol, 2016, 254(5): 835-844.

王文卓. 视网膜静脉阻塞继发黄斑水肿的抗VEGF药物治疗进展[J]. 中国医药指南, 2018, 16(8): 8-9.

EPSTEIN D L, ALGVERE P V, VON WENDT G, et al. Bevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical study[J]. Ophthalmology, 2012, 119(6): 1184-1189.

SUN Y, QU Y. Comparison of intravitreal bevacizumab with intravitreal triamcinolone acetonide for treatment of cystoid macular edema secondary to retinal vein occlusion: a Meta-analysis[J]. Int J Ophthalmol, 2015, 8(6): 1234-1239.

ZHANG L L, KE Y F, WANG W, et al. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coats' disease[J]. Graefes Arch Clin Exp Ophthalmol, 2018, 256(7): 1339-1346.

张万虎, 何亚茹, 宋瑜, 等. 康柏西普与贝伐单抗玻璃体腔注射治疗新生血管性老年性黄斑变性疗效对比观察[J]. 当代医学, 2018, 24(8): 12-15.

陆慧琴, 武炳慧, 吴惠琴. 玻璃体腔注射康柏西普治疗视网膜静脉阻塞并黄斑水肿[J]. 国际眼科杂志, 2016, 16(12): 2264-2267.

邢凯, 亢泽峰. 玻璃体腔内注射康柏西普治疗视网膜分支静脉阻塞继发黄斑水肿的疗效分析[J]. 山东大学耳鼻喉眼学报, 2016, 30(1): 80-82.

毕燃, 贾彩华, 于越, 等. 康柏西普治疗视网膜静脉阻塞黄斑水肿的临床观察[J]. 赤峰学院学报: 自然科学版, 2014, 30(23): 71-73.

左韬, 赵磊, 张祝强, 等. 渗湿明目疗法治疗视网膜分支静脉阻塞型黄斑水肿研究[J]. 辽宁中医杂志, 2016, 43(11): 2326-2329

, 2461.

于菲菲, 庞国龙. 活血化瘀中药辅助治疗视网膜分支静脉阻塞的有效性评价[J]. 世界最新医学信息文摘, 2017, 17(A1): 135.

吴虎强, 张安婷, 王楠楠, 等. 刘楚玉教授运用养血活血、通络利水法论治视网膜静脉阻塞性黄斑水肿的经验[J]. 中国中医急症, 2018, 27(8): 1476-1478.

王泉忠. 用中医辩证分型疗法治疗视网膜静脉阻塞的效果观察[J]. 当代医药论丛, 2014, 12(18): 25-26.

赵邵增. 复方血栓通胶囊治疗视网膜静脉阻塞临床疗效观察[J]. 河南医学研究, 2015, 24(1): 122-122.

刘坚, 张进, 刘文婷, 等. 张仁针刺治疗视网膜静脉阻塞黄斑水肿经验[J]. 中国中医眼科杂志, 2017, 27(1): 14-18.

PARK D H, KIM I T. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion[J]. Retina(Philadelphia, Pa), 2010, 30(1): 117-124.

OSTERLOH M D, CHARLES S. Surgical decompression of branch retinal vein occlusions[J]. Arch Ophthalmol, 1988, 106(10): 1469-1471.

李林, 郭疆, 司马晶, 等. 动静脉鞘膜切开治疗视网膜分支静脉阻塞[J]. 临床眼科杂志, 2012, 20(5): 426-427.

TOMOMATSU Y, TOMOMATSU T, TAKAMURA Y, et al. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions[J]. Acta Ophthalmol, 2016, 94(3): e225-e230.

AZAD S V, SALMAN A, MAHAJAN D, et al. Comparative evaluation between ranibizumab combined with laser and bevacizumab combined with laser versus laser alone for macular oedema secondary to branch retinal vein occlusion[J]. Middle East Afr J Ophthalmol, 2014, 21(4): 296-301.

汤兰兰, 赵海金, 陆华文. 曲安奈德联合激光光凝治疗视网膜静脉阻塞继发黄斑水肿[J]. 国际眼科杂志, 2016, 16(5): 975-977.

PICHI F, SPECCHIA C, VITALE L, et al. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion[J]. Am J Ophthalmol, 2014, 157(3): 607-615. e1.

OZKAYA A, CELIK U, ALKIN Z, et al. Comparison between intravitreal triamcinolone with grid laser photocoagulation versus bevacizumab with grid laser photocoagulation combinations for branch retinal vein occlusion[J]. ISRN Ophthalmol, 2013, 2013: 141279.

BERGER A R, CRUESS A F, ALTOMARE F, et al. Optimal treatment of retinal vein occlusion: Canadian expert consensus[J]. Ophthalmologica, 2015, 234(1): 6-25.

Cited By

Cited by

Periodical cited type(1)

侯松，艾正祥，霍世清. 艾司氯胺酮与硫酸镁用于腹腔镜胆囊切除术对老年患者血流动力学、应激反应及术后镇痛的影响比较. 中国内镜杂志. 2025(02): 45-54 .

Other cited types(2)

Get Citation

PDF

XML

Article views (560) PDF downloads (41) Cited by(3)

Turn off MathJax

Article Contents

Abstract

References

Treatment advances of macular edema caused by retinal vein occlusion

Abstract

References

Cited by

Periodical cited type(1)

Other cited types(2)

Catalog

Export File

Citation

Format

Content